{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:45:20Z","timestamp":1778269520254,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/4-5\/188\/Neuro\/2019-NCD-1"],"award-info":[{"award-number":["5\/4-5\/188\/Neuro\/2019-NCD-1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12035-025-05088-w","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:58:45Z","timestamp":1749689925000},"page":"13318-13337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Amelioration of Chemotherapy Induced Neuropathic Pain using Novel Nicotinic Acid Derivatives with possible HCN channel binding ability"],"prefix":"10.1007","volume":"62","author":[{"given":"Akash","family":"Saini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwani","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhawna","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanzeer","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelima","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"5088_CR1","doi-asserted-by":"publisher","unstructured":"Griffiths LA, Duggett NA, Pitcher AL, Flatters SJL (2018) Evoked and ongoing pain-like behaviours in a rat model of paclitaxel-induced peripheral neuropathy. Pain Res Manag\u00a02018:8217613.\u00a0https:\/\/doi.org\/10.1155\/2018\/8217613","DOI":"10.1155\/2018\/8217613"},{"key":"5088_CR2","doi-asserted-by":"publisher","unstructured":"Subramanian SP, Willias M (2013) Matrix metalloproteinase inhibitor COL-3 prevents the development of paclitaxel-induced hyperalgesia in mice.\u00a0Med Princ Pract 22:35\u201341. https:\/\/doi.org\/10.1159\/000341710","DOI":"10.1159\/000341710"},{"key":"5088_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14737167.2018.1467270","volume":"18","author":"G Dranitsaris","year":"2018","unstructured":"Dranitsaris G, Zhu X, Adunlin G, Vincent MD (2018) Cost effectiveness vs. affordability in the age of immuno-oncology cancer drugs. Expert Rev Pharmacoecon Outcomes Res 18:351\u2013357","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"5088_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1515\/revneuro-2018-0094","volume":"30","author":"JT He","year":"2019","unstructured":"He JT, Li XY, Zhao X, Liu X (2019) Hyperpolarization-activated and cyclic nucleotide-gated channel proteins as emerging new targets in neuropathic pain. Rev Neurosci 30:639\u2013649. https:\/\/doi.org\/10.1515\/revneuro-2018-0094","journal-title":"Rev Neurosci"},{"key":"5088_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.physiol.65.092101.142734","volume":"65","author":"RB Robinson","year":"2003","unstructured":"Robinson RB, Siegelbaum SA (2003) Hyperpolarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 65:453\u2013480. https:\/\/doi.org\/10.1146\/annurev.physiol.65.092101.142734","journal-title":"Annu Rev Physiol"},{"key":"5088_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1124\/pr.117.014035","volume":"69","author":"L Sartiani","year":"2017","unstructured":"Sartiani L, Mannaioni G, Masi A et al (2017) The hyperpolarization-activated cyclic nucleotide\u2013gated channels: from biophysics to pharmacology of a unique family of ion channels. Pharmacol Rev 69:354\u2013395","journal-title":"Pharmacol Rev"},{"key":"5088_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/cne.11039","volume":"471","author":"T Notomi","year":"2004","unstructured":"Notomi T, Shigemoto R (2004) Immunohistochemical localization of Ih channel subunits, HCN1\u20134, in the rat brain. J Comp Neurol 471:241\u2013276","journal-title":"J Comp Neurol"},{"key":"5088_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.12.023","volume":"168","author":"C-H Lee","year":"2017","unstructured":"Lee C-H, MacKinnon R (2017) Structures of the human HCN1 hyperpolarization-activated channel. Cell 168:111\u2013120","journal-title":"Cell"},{"key":"5088_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/emmm.201100134","volume":"3","author":"J Descoeur","year":"2011","unstructured":"Descoeur J, Pereira V, Pizzoccaro A et al (2011) Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med 3:266\u2013278","journal-title":"EMBO Mol Med"},{"key":"5088_CR10","doi-asserted-by":"crossref","unstructured":"Young GT, Emery EC, Mooney ER, et al (2014) Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels. PAIN\u00ae 155:1708\u20131719","DOI":"10.1016\/j.pain.2014.05.021"},{"key":"5088_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.pbb.2012.02.012","volume":"101","author":"AM Godin","year":"2012","unstructured":"Godin AM, Ferreira WC, Rocha LTS et al (2012) Nicotinic acid induces antinociceptive and anti-inflammatory effects in different experimental models. Pharmacol Biochem Behav 101:493\u2013498. https:\/\/doi.org\/10.1016\/j.pbb.2012.02.012","journal-title":"Pharmacol Biochem Behav"},{"key":"5088_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4314\/jpb.v12i1.8","volume":"12","author":"O Erharuyi","year":"2015","unstructured":"Erharuyi O, Igbe I, Falodun A et al (2015) Synthesis and antinociceptive activity of methyl nicotinate. J Pharm Bioresour 12:54\u201359","journal-title":"J Pharm Bioresour"},{"key":"5088_CR13","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.2174\/1568026616999160315130832","volume":"16","author":"M Novella Romanelli","year":"2016","unstructured":"Novella Romanelli M, Sartiani L, Masi A et al (2016) HCN Channels Modulators: The Need for Selectivity. Curr Top Med Chem 16:1764\u20131791. https:\/\/doi.org\/10.2174\/1568026616999160315130832","journal-title":"Curr Top Med Chem"},{"key":"5088_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.neuropharm.2014.02.012","volume":"81","author":"SA Kodirov","year":"2014","unstructured":"Kodirov SA, Wehrmeister M, Colom LV (2014) Modulation of HCN channels in lateral septum by nicotine. Neuropharmacology 81:274\u2013282","journal-title":"Neuropharmacology"},{"key":"5088_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s43188-020-00069-8","volume":"37","author":"M Charehsaz","year":"2021","unstructured":"Charehsaz M, Tugcu G, Aydin A (2021) Filling data gap for nicotinic acid, nicotinate esters and nicotinamide for the determination of permitted daily exposure by a category approach. Toxicol Res 37:337\u2013344","journal-title":"Toxicol Res"},{"key":"5088_CR16","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2019.11.006","volume":"179","author":"C-H Lee","year":"2019","unstructured":"Lee C-H, MacKinnon R (2019) Voltage sensor movements during hyperpolarization in the HCN channel. Cell 179:1582\u20131589","journal-title":"Cell"},{"key":"5088_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson MP, Pincus DL, Rapp CS et al (2004) A Hierarchical Approach to All-Atom Protein Loop Prediction. Proteins Struct Funct Genet 55:351\u2013367. https:\/\/doi.org\/10.1002\/prot.10613","journal-title":"Proteins Struct Funct Genet"},{"key":"5088_CR18","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.molcel.2021.05.033","volume":"81","author":"A Saponaro","year":"2021","unstructured":"Saponaro A, Bauer D, Giese MH et al (2021) Gating movements and ion permeation in HCN4 pacemaker channels. Mol Cell 81:2929\u20132943. https:\/\/doi.org\/10.1016\/j.molcel.2021.05.033","journal-title":"Mol Cell"},{"key":"5088_CR19","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"5088_CR20","first-page":"33","volume":"5","author":"H van de Waterbeemd","year":"2002","unstructured":"van de Waterbeemd H (2002) High-throughput and in silico techniques in drug metabolism and pharmacokinetics. Curr Opin Drug Discov Devel 5:33\u201343","journal-title":"Curr Opin Drug Discov Devel"},{"key":"5088_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H Van De Waterbeemd","year":"2003","unstructured":"Van De Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2:192\u2013204","journal-title":"Nat Rev Drug Discov"},{"key":"5088_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"5088_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.toxrep.2019.06.001","volume":"6","author":"S Kaur","year":"2019","unstructured":"Kaur S, Muthuraman A (2019) Ameliorative effect of gallic acid in paclitaxel-induced neuropathic pain in mice. Toxicol reports 6:505\u2013513","journal-title":"Toxicol reports"},{"key":"5088_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0304-3959(01)00363-3","volume":"94","author":"RC Polomano","year":"2001","unstructured":"Polomano RC, Mannes AJ, Clark US, Bennett GJ (2001) A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94:293\u2013304","journal-title":"Pain"},{"key":"5088_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","volume":"107","author":"NB Eddy","year":"1953","unstructured":"Eddy NB, Leimbach D (1953) Synthetic analgesics. II. Dithienylbutenyl-and dithienylbutylamines J Pharmacol Exp Ther 107:385\u2013393","journal-title":"Dithienylbutenyl-and dithienylbutylamines J Pharmacol Exp Ther"},{"key":"5088_CR26","doi-asserted-by":"crossref","unstructured":"Sakurai M, Egashira N, Kawashiri T, et al (2009) Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. PAIN\u00ae 147:165\u2013174","DOI":"10.1016\/j.pain.2009.09.003"},{"key":"5088_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(00)81434-8","volume":"93","author":"B Santoro","year":"1998","unstructured":"Santoro B, Liu DT, Yao H et al (1998) Identification of a Gene Encoding a Hyperpolarization-Activated Pacemaker Channel of Brain. Cell 93:717\u2013729. https:\/\/doi.org\/10.1016\/S0092-8674(00)81434-8","journal-title":"Cell"},{"key":"5088_CR28","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1161\/CIRCEP.115.003070","volume":"8","author":"N Li","year":"2015","unstructured":"Li N, Csepe TA, Hansen BJ et al (2015) Molecular Mapping of Sinoatrial Node HCN Channel Expression in the Human Heart. Circ Arrhythmia Electrophysiol 8:1219\u20131227. https:\/\/doi.org\/10.1161\/CIRCEP.115.003070","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"5088_CR29","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1248\/cpb.c13-00261","volume":"61","author":"NA Khalil","year":"2013","unstructured":"Khalil NA, Ahmed EM, Mohamed KO, Zaitone SA-B (2013) Synthesis of new nicotinic acid derivatives and their evaluation as analgesic and anti-inflammatory agents. Chem Pharm Bull 61:933\u2013940","journal-title":"Chem Pharm Bull"},{"key":"5088_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.neuropharm.2018.01.014","volume":"131","author":"F Resta","year":"2018","unstructured":"Resta F, Micheli L, Laurino A et al (2018) Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy. Neuropharmacology 131:403\u2013413","journal-title":"Neuropharmacology"},{"key":"5088_CR31","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3389\/fphar.2018.01252","volume":"9","author":"L Dini","year":"2018","unstructured":"Dini L, Del Lungo M, Resta F et al (2018) Selective Blockade of HCN1\/HCN2 Channels as a Potential Pharmacological Strategy Against Pain. Front Pharmacol 9:1252. https:\/\/doi.org\/10.3389\/fphar.2018.01252","journal-title":"Front Pharmacol"},{"key":"5088_CR32","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/ALN.0000000000000176","volume":"120","author":"H Zhang","year":"2014","unstructured":"Zhang H, Dougherty PM (2014) Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy. Anesthesiology 120:1463","journal-title":"Anesthesiology"},{"key":"5088_CR33","doi-asserted-by":"publisher","unstructured":"Zajaczkowsk\u0105 R, Kocot-K\u0119pska M, Leppert W, et al (2019) Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci 20 https:\/\/doi.org\/10.3390\/ijms20061451","DOI":"10.3390\/ijms20061451"},{"key":"5088_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","volume":"2","author":"A Areti","year":"2014","unstructured":"Areti A, Yerra VG, Naidu VGM, Kumar A (2014) Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol 2:289\u2013295","journal-title":"Redox Biol"},{"key":"5088_CR35","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1007\/s13311-021-01142-2","volume":"18","author":"EH Bae","year":"2021","unstructured":"Bae EH, Greenwald MK, Schwartz AG (2021) Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues. Neurotherapeutics 18:2384\u20132396. https:\/\/doi.org\/10.1007\/s13311-021-01142-2","journal-title":"Neurotherapeutics"},{"key":"5088_CR36","first-page":"154","volume":"12","author":"H Huang","year":"2019","unstructured":"Huang H, Zhang Z, Huang D (2019) Decreased HCN2 channel expression attenuates neuropathic pain by inhibiting pro-inflammatory reactions and NF-\u03baB activation in mice. Int J Clin Exp Pathol 12:154\u2013163","journal-title":"Int J Clin Exp Pathol"},{"key":"5088_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874205x-v17-e230109-2022-12","volume":"17","author":"S Rajagopal","year":"2023","unstructured":"Rajagopal S (2023) Modulatory Action of Voltage Gated Ion Channels in Inflammation and Inflammatory Pain. Open Neurol J 17:1\u201310. https:\/\/doi.org\/10.2174\/1874205x-v17-e230109-2022-12","journal-title":"Open Neurol J"},{"key":"5088_CR38","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1097\/00001756-199611250-00018","volume":"7","author":"R Wagner","year":"1996","unstructured":"Wagner R, Myers RR (1996) Endoneurial injection of TNF-\u03b1 produces neuropathic pain behaviors. NeuroReport 7:2897\u20132902","journal-title":"NeuroReport"},{"key":"5088_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fgene.2018.00320","volume":"9","author":"Y Gao","year":"2018","unstructured":"Gao Y, Sun N, Wang L et al (2018) Bioinformatics analysis identifies p53 as a candidate prognostic biomarker for neuropathic pain. Front Genet 9:320","journal-title":"Front Genet"},{"key":"5088_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:1\u20139","journal-title":"Signal Transduct Target Ther"},{"key":"5088_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","volume":"38","author":"FA Pinho-Ribeiro","year":"2017","unstructured":"Pinho-Ribeiro FA, Verri WA, Chiu IM (2017) Nociceptor sensory neuron\u2013immune interactions in pain and inflammation. Trends Immunol 38:5\u201319","journal-title":"Trends Immunol"},{"key":"5088_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-7-27","volume":"7","author":"L Leung","year":"2010","unstructured":"Leung L, Cahill CM (2010) TNF-\u03b1 and neuropathic pain-a review. J Neuroinflammation 7:1\u201311","journal-title":"J Neuroinflammation"},{"key":"5088_CR43","doi-asserted-by":"publisher","unstructured":"Sabio G, Davis RJ (2014) TNF and MAP kinase signalling pathways. Semin Immunol 26:237\u2013245. https:\/\/doi.org\/10.1016\/j.smim.2014.02.009","DOI":"10.1016\/j.smim.2014.02.009"},{"key":"5088_CR44","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J (2016) The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med 6:a026104","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5088_CR45","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.neuroscience.2009.10.053","volume":"165","author":"S Li","year":"2010","unstructured":"Li S, He Z, Guo L et al (2010) Behavioral alterations associated with a down regulation of HCN1 mRNA in hippocampal cornus ammon 1 region and neocortex after chronic incomplete global cerebral ischemia in rats. Neuroscience 165:654\u2013661","journal-title":"Neuroscience"},{"key":"5088_CR46","doi-asserted-by":"crossref","unstructured":"Fields S, Jang SK (1990) Presence of a potent transcription activating sequence in the p53 protein. Science (80- ) 249:1046\u20131049","DOI":"10.1126\/science.2144363"},{"key":"5088_CR47","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s10787-021-00877-w","volume":"29","author":"T Huang","year":"2021","unstructured":"Huang T, Li Y, Hu W et al (2021) Dexmedetomidine attenuates haemorrhage-induced thalamic pain by inhibiting the TLR4\/NF-\u03baB\/ERK1\/2 pathway in mice. Inflammopharmacology 29:1751\u20131760","journal-title":"Inflammopharmacology"},{"key":"5088_CR48","doi-asserted-by":"publisher","first-page":"a001271","DOI":"10.1101\/cshperspect.a001271","volume":"1","author":"B Kaltschmidt","year":"2009","unstructured":"Kaltschmidt B, Kaltschmidt C (2009) NF-\u03baB in the nervous system. Cold Spring Harb Perspect Biol 1:a001271","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5088_CR49","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/cancers14051104","volume":"14","author":"S He","year":"2022","unstructured":"He S, Li Q, Huang Q, Cheng J (2022) Targeting protein kinase C for cancer therapy. Cancers (Basel) 14:1104","journal-title":"Cancers (Basel)"},{"key":"5088_CR50","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.3390\/ijms19082164","volume":"19","author":"MF Yam","year":"2018","unstructured":"Yam MF, Loh YC, Tan CS et al (2018) General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci 19:2164","journal-title":"Int J Mol Sci"},{"key":"5088_CR51","doi-asserted-by":"publisher","unstructured":"Amaral E de OS, Line SRP (2021) Current use of effect size or confidence interval analyses in clinical and biomedical research. Scientometrics 126:9133\u20139145https:\/\/doi.org\/10.1007\/s11192-021-04150-3","DOI":"10.1007\/s11192-021-04150-3"},{"key":"5088_CR52","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/bmj.292.6522.746","volume":"292","author":"MJ Gardner","year":"1986","unstructured":"Gardner MJ, Altman DG (1986) Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) 292:746\u2013750","journal-title":"Br Med J (Clin Res Ed)"},{"key":"5088_CR53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/ATVBAHA.111.241836","volume":"32","author":"JE Digby","year":"2012","unstructured":"Digby JE, Martinez F, Jefferson A et al (2012) Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arterioscler Thromb Vasc Biol 32:669\u2013676","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5088_CR54","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.bja.2023.06.067","volume":"131","author":"GR Tibbs","year":"2023","unstructured":"Tibbs GR, Uprety R, Warren JD et al (2023) An anchor-tether \u2018hindered\u2019HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain model. Br J Anaesth 131:745\u2013763","journal-title":"Br J Anaesth"},{"key":"5088_CR55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.chembiol.2023.11.004","volume":"31","author":"E Harde","year":"2024","unstructured":"Harde E, Hierl M, Weber M et al (2024) Selective and brain-penetrant HCN1 inhibitors reveal links between synaptic integration, cortical function, and working memory. Cell Chem Biol 31:577-592.e23. https:\/\/doi.org\/10.1016\/j.chembiol.2023.11.004","journal-title":"Cell Chem Biol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05088-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05088-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05088-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:34:36Z","timestamp":1757745276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05088-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5088"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05088-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experimental protocols were approved by the Institutional Animal Ethics Committee (reference no. PU\/45\/99\/CCSEA\/IAEC\/2022) and conducted according to CCSEA Guidelines for the use and care of experimental animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicabl.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial number"}}]}}